Literature DB >> 20064641

MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study.

Kelly A Volcik1, Stephen Campbell, Lloyd E Chambless, Josef Coresh, Aaron R Folsom, Thomas H Mosley, Hanyu Ni, Lynne E Wagenknecht, Bruce A Wasserman, Eric Boerwinkle.   

Abstract

OBJECTIVE: Genetic variation in matrix metalloproteinase (MMP) promoter regions alter the transcriptional activity of MMPs and has been consistently associated with CHD, presumably through plaque degradation and remodeling. We examined the association of MMP promoter variation with multiple plaque characteristics measured by gadolinium-enhanced MRI among 1700 participants in the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.
METHODS: For the analyses presented here, 1700 participants of the biracial ARIC Carotid MRI Study ( approximately 1000 participants with thick carotid artery walls and approximately 700 randomly sampled participants) were evaluated for associations of MMP genetic variation with multiple plaque characteristics, including carotid artery wall thickness, lipid core and fibrous cap measures. MRI studies were performed on a 1.5T scanner equipped with a bilateral 4-element phased array carotid coil.
RESULTS: Fifty-one percent of the participants were female, 77% white, 23% African American, and the mean age was 70 years. MMP2 C-1306T variant genotypes (CT+TT) were significantly associated with higher cap thickness measures, but not with wall thickness or lipid core measures. Individuals with the CC genotype had approximately 0.1mm thinner cap thickness compared to those carrying a T allele (P=0.02).
CONCLUSION: Genetic variation within the MMP2 promoter region was associated with cap thickness and therefore may influence the role of MMP2 in plaque vulnerability. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20064641      PMCID: PMC2862087          DOI: 10.1016/j.atherosclerosis.2009.12.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  41 in total

1.  Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain.

Authors:  P K Shah; Z S Galis
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

2.  A new paradigm for plaque stabilization.

Authors:  John A Ambrose; Eulogio E Martinez
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

Review 3.  Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.

Authors:  S Ye
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

4.  Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.

Authors:  S Jormsjö; S Ye; J Moritz; D H Walter; S Dimmeler; A M Zeiher; A Henney; A Hamsten; P Eriksson
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

5.  Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery.

Authors:  G Pasterkamp; A H Schoneveld; D J Hijnen; D P de Kleijn; H Teepen; A C van der Wal; C Borst
Journal:  Atherosclerosis       Date:  2000-06       Impact factor: 5.162

6.  Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke.

Authors:  Chun Yuan; Shao-xiong Zhang; Nayak L Polissar; Denise Echelard; Geraldo Ortiz; Joseph W Davis; Elizabeth Ellington; Marina S Ferguson; Thomas S Hatsukami
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

7.  Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results.

Authors:  Bruce A Wasserman; William I Smith; Hugh H Trout; Richard O Cannon; Robert S Balaban; Andrew E Arai
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

8.  Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation.

Authors:  S J Price; D R Greaves; H Watkins
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

Review 9.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

10.  MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics.

Authors:  Bruce A Wasserman; Brad C Astor; A Richey Sharrett; Cory Swingen; Diane Catellier
Journal:  J Magn Reson Imaging       Date:  2010-02       Impact factor: 4.813

View more
  4 in total

Review 1.  Emerging diagnostic and therapeutic molecular imaging applications in vascular disease.

Authors:  Luis H Eraso; Muredach P Reilly; Chandra Sehgal; Emile R Mohler
Journal:  Vasc Med       Date:  2011-02-10       Impact factor: 3.239

2.  NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II.

Authors:  Isabel Diebold; Andreas Petry; Maximilian Burger; John Hess; Agnes Görlach
Journal:  Mol Biol Cell       Date:  2011-09-30       Impact factor: 4.138

3.  Exploring the Mechanism of Hawthorn Leaves Against Coronary Heart Disease Using Network Pharmacology and Molecular Docking.

Authors:  Jie Ding; Jun Wu; Haoran Wei; Sui Li; Man Huang; Yan Wang; Qin Fang
Journal:  Front Cardiovasc Med       Date:  2022-06-16

4.  Attenuated Superoxide Dismutase 2 Activity Induces Atherosclerotic Plaque Instability During Aging in Hyperlipidemic Mice.

Authors:  Aleksandr E Vendrov; Mark D Stevenson; Samthosh Alahari; Hua Pan; Samuel A Wickline; Nageswara R Madamanchi; Marschall S Runge
Journal:  J Am Heart Assoc       Date:  2017-10-27       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.